This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, S. S.
Right arrow Articles by Panicali, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, S. S.
Right arrow Articles by Panicali, D. L.

 Previous Article  |  Next Article 

Journal of Virology, May 2005, p. 6554-6559, Vol. 79, No. 10
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.10.6554-6559.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus

Shawn S. Jackson,1 Petr Ilyinskii,2,{dagger} Valérie Philippon,2 Linda Gritz,2 Alicia Gómez Yafal,2 Kimberly Zinnack,2 Kristin R. Beaudry,1 Kelledy H. Manson,2 Michelle A. Lifton,1 Marcelo J. Kuroda,1 Norman L. Letvin,1* Gail P. Mazzara,2 and Dennis L. Panicali2

Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215,1 Therion Biologics Corporation, Cambridge, Massachusetts 021422

Received 26 September 2004/ Accepted 3 January 2005

Poxvirus vaccine vectors, although capable of eliciting potent immune responses, pose serious health risks in immunosuppressed individuals. We therefore constructed five novel recombinant vaccinia virus vectors which contained overlapping deletions of coding regions for the B5R, B8R, B12R, B13R, B14R, B16R, B18R, and B19R immunomodulatory gene products and assessed them for both immunogenicity and pathogenicity. All five of these novel vectors elicited both cellular and humoral immunity to the inserted HIV-BH10 env comparable to that induced by the parental Wyeth strain vaccinia virus. However, deletion of these immunomodulatory genes did not increase the immunogenicity of these vectors compared with the parental vaccinia virus. Furthermore, four of these vectors were slightly less virulent and one was slightly more virulent than the Wyeth strain virus in neonatal mice. Attenuated poxviruses have potential use as safer alternatives to current replication-competent vaccinia virus. Improved vaccinia virus vectors can be generated by deleting additional genes to achieve a more significant viral attenuation.

* Corresponding author. Mailing address: Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Research East -RE 113, 330 Brookline Ave., Boston, Massachusetts 02215. Phone: (617) 667-2042. Fax: (617) 667-8210. E-mail: nletvin{at}caregroup.harvard.edu.

{dagger} Present address: Hematology/Oncology Division, Beth Israel Deaconess Medical Center, HIM Building, Room 1044, 330 Brookline Avenue, Boston, MA 02215.

Journal of Virology, May 2005, p. 6554-6559, Vol. 79, No. 10
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.10.6554-6559.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»